BioCentury
ARTICLE | Clinical News

Saphris asenapine regulatory update

August 3, 2009 7:00 AM UTC

FDA's Psychopharmacologic Drugs Advisory committee voted 12-0 that Saphris asenapine from Schering-Plough was safe and effective for acute treatment of manic or mixed episodes in adults with bipolar I...